HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Zhou Selected Research

Platinum

6/2024Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial.
5/2024Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
12/2022SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study.
12/2022Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial.
11/2022Does the primary treatment sequence affect post-relapse survival in recurrent epithelial ovarian cancer? A real-world multicentre retrospective study.
10/2022KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China.
1/2022Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study.
1/2022Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA).
1/2022Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study.
1/2022Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer: The APPROVE Randomized Clinical Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Zhou Research Topics

Disease

204Neoplasms (Cancer)
05/2024 - 02/2002
36Neoplasm Metastasis (Metastasis)
04/2024 - 11/2003
33Infections
01/2024 - 06/2010
33Inflammation (Inflammations)
11/2023 - 01/2015
32Hepatocellular Carcinoma (Hepatoma)
08/2023 - 11/2003
24Carcinogenesis
04/2024 - 11/2003
24Breast Neoplasms (Breast Cancer)
01/2023 - 09/2008
22Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2024 - 11/2007
21Ovarian Neoplasms (Ovarian Cancer)
06/2024 - 09/2015
21COVID-19
03/2023 - 01/2020
18Colorectal Neoplasms (Colorectal Cancer)
05/2024 - 04/2009
18Stomach Neoplasms (Stomach Cancer)
01/2024 - 01/2011
17Stroke (Strokes)
03/2024 - 10/2012
17Osteoporosis
01/2022 - 08/2002
16Hypertension (High Blood Pressure)
06/2023 - 09/2010
16Fibrosis (Cirrhosis)
04/2022 - 03/2006
15Body Weight (Weight, Body)
01/2022 - 02/2008
14Hypoxia (Hypoxemia)
12/2022 - 02/2008
13Carcinoma (Carcinomatosis)
06/2024 - 11/2003
12Gouty Arthritis
11/2023 - 02/2014
11Ovarian Epithelial Carcinoma
06/2024 - 11/2015
11Obesity
11/2023 - 09/2010
11Hemorrhage
01/2023 - 10/2012
11Colonic Neoplasms (Colon Cancer)
02/2021 - 04/2007
10Pain (Aches)
03/2024 - 01/2010
10Disease Progression
12/2023 - 01/2013
10Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2023 - 01/2013
10Ischemic Stroke
01/2023 - 11/2018
10Thrombosis (Thrombus)
01/2023 - 11/2003
9Insulin Resistance
12/2023 - 01/2015
9Adenocarcinoma
12/2023 - 01/2009
9Lung Neoplasms (Lung Cancer)
06/2023 - 05/2009
9Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2013
9Alzheimer Disease (Alzheimer's Disease)
10/2021 - 04/2013
8Pancreatic Neoplasms (Pancreatic Cancer)
03/2024 - 01/2006
8Pneumonia (Pneumonitis)
01/2024 - 02/2010
8Pancreatitis
12/2023 - 02/2019
8Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 09/2008
8Liver Neoplasms (Liver Cancer)
02/2023 - 09/2007
8Myocardial Infarction
01/2023 - 02/2009
8Osteosarcoma (Osteogenic Sarcoma)
12/2022 - 01/2015
8Atherosclerosis
01/2019 - 04/2004
7Lymphatic Metastasis
04/2024 - 04/2009
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 09/2012
7Sepsis (Septicemia)
12/2023 - 07/2011
7Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2023 - 02/2008
7Bone Resorption
01/2022 - 01/2011
6Prostatic Neoplasms (Prostate Cancer)
01/2024 - 03/2004
6Asthma (Bronchial Asthma)
11/2023 - 11/2017
6Nasopharyngeal Carcinoma
11/2023 - 01/2018
6Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2023 - 01/2013
6Cognitive Dysfunction
06/2023 - 01/2018
6Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 04/2007
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2023 - 01/2016

Drug/Important Bio-Agent (IBA)

64Proteins (Proteins, Gene)FDA Link
03/2024 - 12/2005
44Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2011
31MicroRNAs (MicroRNA)IBA
11/2023 - 01/2011
20Glucose (Dextrose)FDA LinkGeneric
11/2023 - 03/2008
19LipidsIBA
01/2023 - 01/2006
17Messenger RNA (mRNA)IBA
03/2024 - 01/2006
16PlatinumIBA
06/2024 - 09/2012
16Therapeutic UsesIBA
11/2023 - 01/2006
14DNA (Deoxyribonucleic Acid)IBA
12/2021 - 03/2004
14Small Interfering RNA (siRNA)IBA
01/2020 - 01/2006
13RNA (Ribonucleic Acid)IBA
05/2023 - 01/2006
12CytokinesIBA
11/2023 - 10/2012
12Long Noncoding RNAIBA
11/2023 - 01/2017
12CateninsIBA
08/2022 - 09/2013
11VaccinesIBA
01/2024 - 11/2009
9Blood Glucose (Blood Sugar)IBA
04/2024 - 08/2015
9Insulin (Novolin)FDA Link
12/2023 - 01/2014
9SaponinsIBA
11/2023 - 10/2014
9Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 04/2015
9CalciumIBA
01/2023 - 02/2002
9EnzymesIBA
01/2023 - 06/2014
8Indicators and Reagents (Reagents)IBA
04/2024 - 06/2014
8AntigensIBA
03/2023 - 09/2005
8Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 01/2008
7Paclitaxel (Taxol)FDA LinkGeneric
03/2024 - 12/2005
7LipopolysaccharidesIBA
02/2024 - 01/2018
7Peptides (Polypeptides)IBA
11/2023 - 03/2004
7Uric Acid (Urate)IBA
09/2023 - 11/2015
7AlbuminsIBA
08/2023 - 09/2014
7GlucocorticoidsIBA
05/2023 - 11/2014
7AcidsIBA
10/2022 - 02/2010
7Liposomes (Liposome)IBA
01/2022 - 03/2004
7Retinaldehyde (Retinal)IBA
01/2022 - 01/2015
7Doxorubicin (Adriamycin)FDA LinkGeneric
09/2021 - 03/2008
6olaparibIBA
05/2024 - 10/2017
6Circular RNAIBA
07/2023 - 01/2019

Therapy/Procedure

106Therapeutics
06/2024 - 03/2004
37Drug Therapy (Chemotherapy)
06/2024 - 10/2007
17Immunotherapy
05/2024 - 10/2007
12Transplantation
04/2024 - 10/2007
9Length of Stay
08/2023 - 11/2011
8Anesthesia
03/2024 - 07/2010
7Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2023 - 01/2012
7Artificial Respiration (Mechanical Ventilation)
04/2022 - 07/2011
7Percutaneous Coronary Intervention
01/2022 - 05/2019
6Stents
05/2024 - 12/2005